Search for intracranial aneurysm susceptibility gene(s) using Finnish families
© Olson et al; licensee BioMed Central Ltd. 2002
Received: 27 March 2002
Accepted: 1 August 2002
Published: 1 August 2002
Cerebrovascular disease is the third leading cause of death in the United States, and about one-fourth of cerebrovascular deaths are attributed to ruptured intracranial aneurysms (IA). Epidemiological evidence suggests that IAs cluster in families, and are therefore probably genetic. Identification of individuals at risk for developing IAs by genetic tests will allow concentration of diagnostic imaging on high-risk individuals. We used model-free linkage analysis based on allele sharing with a two-stage design for a genome-wide scan to identify chromosomal regions that may harbor IA loci.
We previously estimated sibling relative risk in the Finnish population at between 9 and 16, and proceeded with a genome-wide scan for loci predisposing to IA. In 85 Finnish families with two or more affected members, 48 affected sibling pairs (ASPs) were available for our genetic study. Power calculations indicated that 48 ASPs were adequate to identify chromosomal regions likely to harbor predisposing genes and that a liberal stage I lod score threshold of 0.8 provided a reasonable balance between detection of false positive regions and failure to detect real loci with moderate effect.
Seven chromosomal regions exceeded the stage I lod score threshold of 0.8 and five exceeded 1.0. The most significant region, on chromosome 19q, had a maximum multipoint lod score (MLS) of 2.6.
Our study provides evidence for the locations of genes predisposing to IA. Further studies are necessary to elucidate the genes and their role in the pathophysiology of IA, and to design genetic tests.
In spite of advances in surgical and pharmacological treatment, about half of the aneurysmal subarachnoid hemorrhage (SAH) patients die and many who survive need rehabilitation to maintain independence, causing significant economic losses to medical and social care. About 90% of SAH cases are caused by a ruptured IA . Per-case mortality for ruptured IAs is about 30 to 50% and morbidity about 66% as opposed to about 2% mortality and 4% morbidity for elective surgery of unruptured IAs in asymptomatic low-risk patients [2, 3]. Given the marked contrast between the outcomes of elective versus emergency surgery, the goal has to be identification and treatment of IAs prior to rupture.
There is substantial debate regarding the cost-benefit ratio of population screening [4–8]. Restricting screening to those individuals at high risk both for developing IA and for rupture would improve the cost-benefit ratio. Characterization of environmental and genetic risk factors would allow not only reduction of risk through behavior modification, but also significantly improve detection. Additionally, some environmental and genetic risk factors may be amenable to pharmacological intervention. Simple tests for genetic risk factors would permit the identification of individuals at high risk for development and rupture of aneurysms, consequently allowing diagnostic effort to be concentrated on a smaller group that is at higher risk.
Currently, several risk factors have been identified including cigarette smoking, arterial hypertension, gender, aging, atherosclerosis and heavy alcohol consumption [9–12]. Initial indications of a genetic component were based on collections of case reports that suggested that IAs are associated with some rare simple Mendelian disorders, e.g. autosomal dominant polycystic kidney disease, Ehlers Danlos syndrome type IV and the Marfan syndrome . More recent systematic prevalence estimates indicate either absence of association or markedly reduced prevalence of IA among patients with rare simple Mendelian disorders [14, 15]. Also, genetic analyses of genes known to cause some simple Mendelian disorders have proven negative for collections of patients with IA [16, 17]. The familial occurrence of IAs not associated with known simple Mendelian disorders was first noted in 1942  and, since then, nearly one hundred case reports and review articles have been published. Population-based studies of SAH probands show that 7 to 10% have a family history of IA, a higher percentage than previously appreciated [1, 19, 20]. These familial IA (FIA) families have no signs of any other simple Mendelian disorders predisposing to IA, supporting the possibility that some or all IAs have a genetic component, and that FIA is a genetic disease separate and apart from previously defined diseases. The inheritance patterns of FIA have not been determined, partly because IA is a late age-at-onset disease and partly because it is likely to be a multifactorial disease for which simple Mendelian models will not fit well [1, 21–23].
Distribution of Affected Sibship Sizes
The study protocol was reviewed and approved by the Institutional Review Boards of both the University Hospital of Kuopio and Wayne State University.
Whole-genome scans are labor-intensive and costly since each individual in the study must be genotyped for all markers. Reduction of the number of samples genotyped, or the number of markers, or both, has been shown to be efficient [24–28]. We used a two-stage design. In stage 1, samples are genotyped at low density and subsequently at higher density in stage 2, thereby reducing the overall number of markers genotyped. Stage 1 data were analysed using a liberal α ≈ 0.05 (lod = 0.8). Regions exceeding the threshold were genotyped in stage 2.
Power was computed assuming a two-stage design, 49 ASPs, and a map density of 15 cM. For stage I alone, we had at least 96% power to detect "significant linkage" (lod score of 3.6)  to a locus with a locus-specific relative risk to siblings of 8 and at least 90% power to detect "suggestive linkage" to a locus with a locus-specific relative risk of 4.
DNA isolation and pre-amplification
Blood was collected into EDTA-containing tubes. Genomic DNA was isolated either by an automated procedure (Genepure DNA extractor, Applied Biosystems, Inc., Foster City, CA) or manually (Puregene DNA isolation kit, Gentra Systems, Inc., Minneapolis, MN). Genotyping was performed using genomic DNA, either untreated or amplified linearly using primer-extension preamplification [30, 31]. Approximately 0.5 μg genomic DNA was used for preamplification with an N15-primer [30, 31]. The resulting preamplified DNA was then used as a template in marker PCRs with specific primers.
Most of the initial genotyping was performed by the National Heart Lung and Blood Institute Mammalian Genotyping Service at the Marshfield Research Foundation using the 10 cM Weber version 8 screening set . Primer pairs for additional markers were obtained from Research Genetics, Inc. (Huntsville, AL). For the additional genotyping, PCRs were carried out with one of the primers radioactively labeled. PCRs were set up using a laboratory workstation (Biomek 1000; Beckman, Palo Alto, CA) and performed in PEC 9600 thermal cyclers (Perkin Elmer Cetus, Foster City, CA). The alleles were scored visually from autoradiographs and entered into an Oracle database (Oracle Corp., Redwood Shores, CA). Population frequencies for each marker were estimated from a sample of 20 to 24 unrelated Finnish subjects.
A Markov-process-based test of genetic relationship  using all the marker data across the genome was used on each nuclear family to confirm the sib-pair relationship; one non-sib pair was detected in one of the sibships in family 21 (Figure. 1) and eliminated from the analyses. The results were consequently derived from 24 sibships (Figure 1).
Genome-wide linkage analysis
Maximum MLSs for the seven regions exceeding the stage 1 threshold
Distance (cM) from pter
D4S2366 – D4S403
D19S245 – D19S246
The relatively high prevalence of IAs and aneurysmal SAH place the disease in the group of moderately common disorders. Consequently, it shares some of the features that make common disorders complex with respect to genetic analysis. These include: low sibling relative risks due to the high population prevalence; presence of multiple genetic loci, each contributing a small portion of the sibling relative risk; incomplete penetrance of genetic loci; environmental risk factors; late age at onset; and phenocopies, i.e. disease due to purely environmental factors. Additional complexity for genetic analysis arises due to diagnostic uncertainty. Several measures were taken to increase the probability of success. We used robust, model-free, allele-sharing genetic analyses to address the complexity, we studied a relatively genetically homogenous population, and we verified that all putative IAs were saccular [1, 20, 41–43]. It is expected that a genetically homogeneous population, particularly one with a recent population bottleneck [37, 38], segregates for fewer disease loci thereby allowing a smaller sample size to be informative. Additionally, our study design was cost-effective, two-stage design with 48 ASPs. We are collecting an additional 150 ASPs for further study.
The most promising locus with a maximum MLS of 2.6 was on chromosome 19. The peak is located approximately in 19q12–13, a gene-rich region containing a number of loci related to cerebrovascular, cardiovascular and membrane physiology and pathobiology. These include urokinase-type plasminogen activator receptor (PLAUR; MIM 173391, see Online Mendelian Inheritance in Man http://www.ncbi.nlm.nih.gov/omim/) , apolipoproteins E (MIM 107741), CII (MIM 207750) and CI (MIM 107710), human brain-specific Na(+)-dependent inorganic phosphate cotransporter (hBNPI, 19q13) , cardiac troponin I (TnIc, 19q; MIM 191044) [46, 47], cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL, caused by mutations in the Notch3 gene, 19q12; MIM 602275) , isolated cardiac conduction disease (19q13.3; MIM 113900) , and progressive familial heart block type I (PF-HBI, 19q13.2–13.3; MIM 113900) . Mutations in the P/Q-type Ca(2+)-channel alpha 1A-subunit gene on 19q12 cause familial hemiplegic migraine, episodic ataxia type 2, and spinocerebellar ataxia type 6 (MIM 141500) [51, 52].
It is noteworthy that none of the regions in which we found some evidence for linkage, either tentative or suggestive, are similar to the regions detected in another recent genome-wide scan for IA susceptibility genes . Although our study found evidence for a region with tentative linkage on chromosome 7q, the region identified in this study is near the telomere and does not overlap with the region of suggestive linkage near the centromere on 7q identified in Onda et al. . The populations that were studied are distinct, Finns as compared to Japanese; however, both samples were small and it is therefore possible that there may yet be some overlap in genetic predisposition.
We detected two regions of suggestive linkage, one on chromosome 19 and the other on the X chromosome in a sample of Finnish ASPs. Although we initially detected regions of tentative linkage on chromosomes 4, 6, 7p, 7q and 14, the regions on 7p and 14 were excluded upon additional genotyping. None of the regions detected in this study overlap with the regions detected in a sample of Japanese ASPs .
We thank Dr. James Weber and the National Heart Lung and Blood Institute Mammalian Genotyping Service at the Marshfield Medical Research Foundation, Marshfield, WI, for performing the initial, and majority, of the genotyping for the genome scan.
Supported by funds from Wayne State University School of Medicine, University of Kuopio, the American Heart Association, Michigan Affiliate (to G.T.), a grant from the National Institute for Neurological Disorders and Stroke (NINDS) (NS34395 to G.T.), a grant from the National Center for Human Genome Research (HG01577) (to J.M.O.) and a grant from the National Center for Research Resources (RR03655).
- Ronkainen A, Hernesniemi J, Puranen M, Niemitukia L, Vanninen R, Ryynänen M, Kuivaniemi H, Tromp G: Familial intracranial aneurysms. The Lancet. 1997, 349: 380-384. 9033463.View ArticleGoogle Scholar
- Heiskanen O: Risks of surgery for unruptured intracranial aneurysms. Journal of Neurosurgery. 1986, 65: 451-453.View ArticlePubMedGoogle Scholar
- King JT, Berlin JA, Flamm ES: Morbidity and mortality from elective surgery for asymptomatic, unruptured, intracranial aneurysms: a meta-analysis. Journal of Neurosurgery. 1994, 81: 837-842.View ArticlePubMedGoogle Scholar
- Johnston SC, Gress DR, Kahn JG: Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology. 1999, 52: 1806-1815.View ArticlePubMedGoogle Scholar
- Crawley F, Clifton A, Brown MM: Should we screen for familial intracranial aneurysm?. Stroke. 1999, 30: 312-316.View ArticlePubMedGoogle Scholar
- Yoshimoto Y, Wakai S: Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms: A mathematical model. Stroke. 1999, 30: 1621-1627.View ArticlePubMedGoogle Scholar
- King JT, Glick HA, Mason TJ, Flamm ES: Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. Journal of Neurosurgery. 1995, 83: 403-412.View ArticlePubMedGoogle Scholar
- ISUIA consortium: Unruptured intracranial aneurysms–risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. New England Journal of Medicine. 1998, 339: 1725-1733. 10.1056/NEJM199812103392401.View ArticleGoogle Scholar
- Weir B: Intracranial aneurysms and subarachnoid hemorrhage: an overview. In: Neurosurgery. Edited by: Wilkins RH, Rengarchy SS. 1985, New York: McGraw-Hill Book Company, 2: 1308-1329.Google Scholar
- Fogelholm R, Hernesniemi J, Vapalahti M: Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke. 1993, 24: 1649-1654.View ArticlePubMedGoogle Scholar
- Sekhar LN, Heros RC: Origin, growth, and rupture of saccular aneurysms: a review. Neurosurgery. 1981, 8: 248-260.View ArticlePubMedGoogle Scholar
- Juvela S, Hillbom M, Numminen H, Koskinen P: Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993, 24: 639-646.View ArticlePubMedGoogle Scholar
- Schievink WI: Intracranial aneurysms. New England Journal of Medicine. 1997, 336: 28-40. 10.1056/NEJM199701023360106.View ArticlePubMedGoogle Scholar
- Cloft HJ, Kallmes DF, Kallmes MH, Goldstein JH, Jensen ME, Dion JE: Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. Journal of Neurosurgery. 1998, 88: 436-440.View ArticlePubMedGoogle Scholar
- van den Berg JS, Limburg M, Hennekam RC: Is Marfan syndrome associated with symptomatic intracranial aneurysms?. Stroke. 1996, 27: 10-12.View ArticlePubMedGoogle Scholar
- Kuivaniemi H, Prockop DJ, Wu Y, Madhatheri SL, Kleinert C, Earley JJ, Jokinen A, Stolle C, Majamaa K, Myllyla VV, Norrgård Ö, Schievink WI, Mokri B, Fukawa O, ter Berg HWM, De Paepe A, Lozano AM, Leblanc R, Ryynänen M, Baxter BT, Shikata H, Ferrell RE, Tromp G: Exclusion of mutations in the gene for type III collagen (COL3A1) as a common cause of intracranial aneurysms or cervical artery dissections: results from sequence analysis of the coding sequences of type III collagen from 55 unrelated patients. Neurology. 1993, 43: 2652-2658.View ArticlePubMedGoogle Scholar
- van den Berg JS, Pals G, Arwert F, Hennekam RC, Albrecht KW, Westerveld A, Limburg M: Type III collagen deficiency in saccular intracranial aneurysms: defect in gene regulation?. Stroke. 1999, 30: 1628-1631.View ArticlePubMedGoogle Scholar
- O'Brien JG: Subarachnoid hemorrhage in identical twins. British Medical Journal. 1942, 607-609.Google Scholar
- Norrgård Ö, Ängquist KA, Fodstad H, Forsell Ä, Lindberg M: Intracranial aneurysms and heredity. Neurosurgery. 1987, 20: 236-239.View ArticlePubMedGoogle Scholar
- Ronkainen A, Hernesniemi J, Ryynänen M: Familial subarachnoid hemorrhage in east Finland, 1977–1990. Neurosurgery. 1993, 33: 787-796.View ArticlePubMedGoogle Scholar
- Schievink WI, Schaid DJ, Rogers HM, Piepgras DG, Michels VV: On the inheritance of intracranial aneurysms. Stroke. 1994, 25: 2028-2037.View ArticlePubMedGoogle Scholar
- Ronkainen A, Hernesniemi J, Tromp G: Special features of familial intracranial aneurysms: report of 215 familial aneurysms. Neurosurgery. 1995, 37: 43-46.View ArticlePubMedGoogle Scholar
- Ronkainen A, Miettinen H, Karkola K, Papinaho S, Vanninen R, Puranen M, Hernesniemi J: Risk of harboring an unruptured intracranial aneurysm. Stroke. 1998, 29: 359-362.View ArticlePubMedGoogle Scholar
- Elston RC, Guo X, Williams LV: Two-stage global search designs for linkage analysis using pairs of affected relatives. Genetic Epidemiology. 1996, 13: 535-558. 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.0.CO;2-#.View ArticlePubMedGoogle Scholar
- Guo X, Elston RC: One-stage versus two-stage strategies for genome scans. Advances in Genetics. 2001, 42: 459-471. 10.1016/S0065-2660(01)42036-0.View ArticlePubMedGoogle Scholar
- Guo X, Elston RC: Two-stage global search designs for linkage analysis I: use of the mean statistic for affected sib pairs. Genetic Epidemiology. 2000, 18: 97-110. 10.1002/(SICI)1098-2272(200002)18:2<97::AID-GEPI1>3.0.CO;2-J.View ArticlePubMedGoogle Scholar
- Guo X, Elston RC: Two-stage global search designs for linkage analysis II: including discordant relative pairs in the study. Genetic Epidemiology. 2000, 18: 111-127. 10.1002/(SICI)1098-2272(200002)18:2<111::AID-GEPI2>3.3.CO;2-D.View ArticlePubMedGoogle Scholar
- Holmans P, Craddock N: Efficient strategies for genome scanning using maximum-likelihood affected-sib-pair analysis. American Journal of Human Genetics. 1997, 60: 657-666.PubMedPubMed CentralGoogle Scholar
- Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genetics. 1995, 11: 241-247.View ArticlePubMedGoogle Scholar
- Kuivaniemi H, Yoon S, Shibamura H, Skunca M, Vongpunsawad S, Tromp G: Primer-extension preamplified DNA is a reliable template for genotyping. Clinical Chemistry.
- Zhang L, Cui X, Schmitt K, Hubert R, Navidi W, Arnheim N: Whole genome amplification from a single cell: implications for genetic analysis. Proceedings of the National Academy of Sciences of the United States of America. 1992, 89: 5847-5851.View ArticlePubMedPubMed CentralGoogle Scholar
- Yuan B, Vaske D, Weber JL, Beck J, Sheffield VC: Improved set of short-tandem-repeat polymorphisms for screening the human genome. American Journal of Human Genetics. 1997, 60: 459-460.PubMedPubMed CentralGoogle Scholar
- Olson JM: Relationship estimation by Markov-process models in a sib-pair linkage study. American Journal of Human Genetics. 1999, 64: 1464-1472.View ArticlePubMedPubMed CentralGoogle Scholar
- Risch N: Linkage strategies for genetically complex traits. I. Multilocus models. American Journal of Human Genetics. 1990, 46: 222-228.PubMedPubMed CentralGoogle Scholar
- Kruglyak L, Lander ES: Complete multipoint sib-pair analysis of qualitative and quantitative traits. American Journal of Human Genetics. 1995, 57: 439-454.PubMedPubMed CentralGoogle Scholar
- Norio R: Diseases of Finland and Scandinavia. In: Biocultural aspects of disease. Edited by: Rothschild H. 1981, New York: Academic Press Inc, 359-415.Google Scholar
- de la Chapelle A, Wright FA: Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proceedings of the National Academy of Sciences of the United States of America. 1998, 95: 12416-12423. 10.1073/pnas.95.21.12416.View ArticlePubMedPubMed CentralGoogle Scholar
- de la Chapelle A: Disease gene mapping in isolated human populations: the example of Finland. Journal of Medical Genetics. 1993, 30: 857-865.View ArticlePubMedPubMed CentralGoogle Scholar
- Peltonen L, Pekkarinen P, Aaltonen J: Messages from an isolate: lessons from the Finnish gene pool. Biological Chemistry Hoppe-Seyler. 1995, 376: 697-704.View ArticlePubMedGoogle Scholar
- Peltonen L: Positional cloning of disease genes: advantages of genetic isolates. Human Heredity. 2000, 50: 66-75. 10.1159/000022892.View ArticlePubMedGoogle Scholar
- Ronkainen A, Hernesniemi J, Ryynänen M, Puranen M, Kuivaniemi H: A ten percent prevalence of asymptomatic familial intracranial aneurysms: preliminary report on 110 magnetic resonance angiography studies in members of 21 Finnish familial intracranial aneurysm families. Neurosurgery. 1994, 35: 208-212.View ArticlePubMedGoogle Scholar
- Vanninen RL, Hernesniemi JA, Puranen MI, Ronkainen A: Magnetic resonance angiographic screening for asymptomatic intracranial aneurysms: the problem of false negatives: technical case report. Neurosurgery. 1996, 38: 838-840.View ArticlePubMedGoogle Scholar
- Ronkainen A, Puranen MI, Hernesniemi JA, Vanninen RL, Partanen PL, Saari JT, Vainio PA, Ryynänen M: Intracranial aneurysms: MR angiographic screening in 400 asymptomatic individuals with increased familial risk. Radiology. 1995, 195: 35-40.View ArticlePubMedGoogle Scholar
- Casey JR, Petranka JG, Kottra J, Fleenor DE, Rosse WF: The structure of the urokinase-type plasminogen activator receptor gene. Blood. 1994, 84: 1151-1156.PubMedGoogle Scholar
- Ni B, Du Y, Wu X, DeHoff BS, Rosteck PR, Paul SM: Molecular cloning, expression, and chromosomal localization of a human brain-specific Na(+)-dependent inorganic phosphate cotransporter. Journal of Neurochemistry. 1996, 66: 2227-2238.View ArticlePubMedGoogle Scholar
- Bermingham N, Hernandez D, Balfour A, Gilmour F, Martin JE, Fisher EM: Mapping TNNC1, the gene that encodes cardiac troponin I in the human and the mouse. Genomics. 1995, 30: 620-622. 10.1006/geno.1995.1288.View ArticlePubMedGoogle Scholar
- Bhavsar PK, Brand NJ, Yacoub MH, Barton PJR: Isolation and characterization of the human cardiac troponin I gene (TNNI3). Genomics. 1996, 35: 11-23. 10.1006/geno.1996.0317.View ArticlePubMedGoogle Scholar
- Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E: Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996, 383: 707-710. 10.1038/383707a0.View ArticlePubMedGoogle Scholar
- de Meeus A, Stephan E, Debrus S, Jean MK, Loiselet J, Weissenbach J, Demaille J, Bouvagnet P: An isolated cardiac conduction disease maps to chromosome 19q. Circulation Research. 1995, 77: 735-740.View ArticlePubMedGoogle Scholar
- Brink PA, Ferreira A, Moolman JC, Weymar HW, van der Merwe PL, Corfield VA: Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation. 1995, 91: 1633-1640.View ArticlePubMedGoogle Scholar
- Ophoff RA, Terwindt GM, Vergouwe MN, Frants RR, Ferrari MD: Involvement of a Ca2+ channel gene in familial hemiplegic migraine and migraine with and without aura. Headache. 1997, 37: 479-485. 10.1046/j.1526-4610.1997.3708479.x.View ArticlePubMedGoogle Scholar
- Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G, Calandriello L, Francia A, Spadaro M, Pierelli F, Salvi F, Ophoff RA, Frants RR, Frontali M: Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Human Molecular Genetics. 1997, 6: 1973-1978. 10.1093/hmg/6.11.1973.View ArticlePubMedGoogle Scholar
- Onda H, Kasuya H, Yoneyama T, Takakura K, Hori T, Takeda J, Nakajima T, Inoue I: Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. American Journal of Human Genetics. 2001, 69: 804-819. 10.1086/323614.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/3/7/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.